Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
about
Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesCetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.CD56+ T cells inhibit hepatitis C virus replication in human hepatocytesAqueous extracts from dietary supplements influence the production of inflammatory cytokines in immortalized and primary T lymphocytes.Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancerExpression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma.Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival.Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patientsAdministration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response.Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.IFNα2b augments immune responses of cisplatin+5-fluorouracil treated tongue squamous cell carcinoma patients--a preliminary study.Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functionsEvidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma.Effect of treatment on systemic cytokines in head and neck squamous cell carcinoma patients.Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity.Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytesRole of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma.HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.Cordycepin and a preparation from Cordyceps militaris inhibit malignant transformation and proliferation by decreasing EGFR and IL-17RA signaling in a murine oral cancer model.Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.[The systemic evaluation and clinical significance of immunological function for advanced lung cancer patients].Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease.
P2860
Q26765429-0E8FAE29-9648-4CFD-A95E-D129285A9115Q27001081-2392F948-BBB5-49B1-9C5A-1B3294FBB168Q27329648-51BA954D-5C92-47C2-B32E-0402F73AAA08Q27488358-E9E45324-10F8-48A2-A7B7-3F8C33B35143Q33517999-CD1496CB-5570-4DB3-B3C7-A5C7E6DA191AQ33546659-823DDF60-5E19-4E07-89E5-760C82BFEF80Q33707786-38ED5ECD-93D4-4A7B-BEAB-81528E7B32AEQ33802831-826CC9C6-289B-4CAC-9BAE-633CBFB5646AQ33820247-59131325-EFAE-48CB-9CC6-C442B0AAA7F1Q34516135-2E8CA3CA-B5BA-425F-917A-3229CD498325Q35644535-0E3CAE2E-9865-4DB8-96EA-46A8D24AFCF0Q35965142-C524364A-2AAD-4E7B-9601-FE17C46CA308Q36024702-397AA303-80AB-4F29-9471-409E4FD3AAB6Q36110266-7C1FB998-C951-4C1D-8C3F-9BEB9DE4A6E8Q36289634-01B805A8-FE39-4F43-8034-4F063D0DB09CQ36587186-58DD7614-0891-4DEE-A0FA-DC97A04398A1Q37274307-79109D59-EEDA-4BE7-ADF2-01663AB01C1CQ37346143-1041FD6C-23CA-47D2-A40E-5283E28A74E5Q37352465-E1B9B039-A7D8-4EB4-B59C-2E667B261BC1Q37375286-AFD1455A-DFE9-4083-9D42-2A4E675307D9Q37390393-CB8D00C2-8A99-4438-9368-DCF54CBFD9D9Q37728654-9159B70B-8C52-46E5-8FC6-1F7167D846D6Q37743484-D005587B-3BCD-4E5D-B18A-50ACA43AA34CQ39650631-268467EA-6BE6-4A9B-82FA-D2882830ADA1Q39750536-C2EBB45D-4467-48D1-A7F5-BAA680E42D8EQ40979257-AFE551FF-9967-4436-B13D-E818B73DAE4EQ42365249-3C893CD3-35A0-4E2A-A4D0-7455B2CF90E6Q47139326-1E4D1453-CB76-454B-8267-3547FC881DA6Q48799977-F7CF5DD5-040D-430E-8BF1-3CFBF5E0F5B2Q53109856-9BFDE951-2E3E-49FB-9457-F10D33B3FFF0Q55430751-A52D713A-7922-4BE6-A434-23CCECE27834Q55515189-71CD1633-902E-47DE-9814-EB0E11ED09DA
P2860
Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dysregulation in immune functi ...... amous cell carcinoma patients.
@ast
Dysregulation in immune functi ...... amous cell carcinoma patients.
@en
Dysregulation in immune functi ...... amous cell carcinoma patients.
@nl
type
label
Dysregulation in immune functi ...... amous cell carcinoma patients.
@ast
Dysregulation in immune functi ...... amous cell carcinoma patients.
@en
Dysregulation in immune functi ...... amous cell carcinoma patients.
@nl
prefLabel
Dysregulation in immune functi ...... amous cell carcinoma patients.
@ast
Dysregulation in immune functi ...... amous cell carcinoma patients.
@en
Dysregulation in immune functi ...... amous cell carcinoma patients.
@nl
P2093
P2860
P1433
P1476
Dysregulation in immune functi ...... uamous cell carcinoma patients
@en
P2093
Anamika Bose
Krishnendu Chakraborty
Rathindranath Baral
Smarajit Pal
Tathagata Chakraborty
P2860
P577
2008-06-12T00:00:00Z